07:30 EST Abbott (ABT) to acquire Exact Sciences (EXAS) for $105 per share, or equity value ~$21B
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Abbott Laboratories’ Strategic Acquisition of Exact Sciences Drives Buy Rating
- Mizuho says $100 per share takeout price for Exact Sciences ‘feasible’
- Abbott Laboratories’ Strategic Acquisition of Exact Sciences: A Catalyst for Diagnostics Growth and Market Expansion
- BofA moves to No Rating on Exact Sciences after Abbott report
- Strategic Acquisition and Growth Prospects Drive Buy Rating for Abbott Laboratories